Carregant...

Selective Estrogen Receptor Modulators to Prevent Treatment-Related Osteoporosis

The intended therapeutic effect of gonadotropin-releasing hormone (GnRH) agonists is hypogonadism, which is a leading cause of osteoporosis in men. Consistent with this observation, GnRH agonists decrease bone mineral density and increase fracture risk in men with prostate cancer. GnRH agonists mark...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autor principal: Smith, Matthew R
Format: Artigo
Idioma:Inglês
Publicat: MedReviews, LLC 2005
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1550783/
https://ncbi.nlm.nih.gov/pubmed/16985877
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!